Truist Financial
PPH icon

Truist Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Truist Financial’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Buy
2,364
+130
+6% +$13.8K ﹤0.01% 2525
2025
Q4 		$230K Buy
+2,234
New +$217K ﹤0.01% 2510

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Truist Financial's PPH Position: Q1 2026 in Review

Truist Financial increased its VanEck Pharmaceutical ETF (PPH) stake by 5.8% in Q1 2026, buying an estimated $13.8K and bringing the position to 2,364 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #2525.

Truist Financial first reported a position in PPH in Q4 2025 and has held it in 2 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Truist Financial held 2,364 shares of VanEck Pharmaceutical ETF worth $246K as of Q1 2026.
  • Truist Financial bought 130 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $13.8K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Truist Financial's portfolio in Q1 2026, its #2525 holding.
  • Truist Financial first reported a position in VanEck Pharmaceutical ETF in Q4 2025 and has held it in 2 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.